Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	448
Effect of fetal apolipoprotein L1 genotype and vitamin D deficiencies on preeclampsia risk	111
Associations of Diabetes, Mental Health, and Asthma with Hypertensive Disorders of Pregnancy: A Population-based Case-Control Study in Alberta, Canada	44
Circulating concentrations of pro-inflammatory cytokines in preeclampsia with varying disease severity	37
Title Page	36
Birthweight in a non-human primate model of placental ischaemia	26
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	20
Fetomaternal outcome of Sysytemic Lupus erythematosus in pregnancy -case reports	18
Increased incidence of eclampsia in adolescents in low- and middle-income settings	17
Calcium aspirin preeclampsia early prevention and response (CASPER) study; a double blinded cluster randomized trial	17
Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	17
Diet and physical activity of women 6-months following a hypertensive pregnancy: A BP2 sub-study	16
A novel biomarker – Maternal glycosylated fibronectin for prognostication of preeclampsia	15
Postpartum hemorrhage as a masquerader of Systemic Lupus Erythematosis (SLE)- An Obstetric Near Miss	15
Knowledge attitude and practices regarding pregnancy induced hypertension among ASHA workers – A possible link to reduce related adverse outcomes	15
A comparative study of hypertensive disorders of pregnancy in women with and without gestational diabetes mellitus	15
Fetal microchimerism (FMc) correlates with both stages of the two-stage model of preeclampsia – A potential link to future maternal cardiovascular risk?	14
Identifying genetic risk loci associated with cardiovascular disease progression following preeclampsia: A genome-wide association study	14
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	14
The anti-hypertensive effects of Dombeya rotundifolia in an arginine vasopressin rat model of pre-eclampsia	14
Early onset pre-eclampsia and its effect on future pregnancy outcomes	13
Prevalence of perinatal mortality in hypertensive disorders of pregnancy	13
Hypertensive disorders of pregnancy following Invitro fertilization among autologous and donor cycles: A retrospective cohort study	13
Comparison of ophthalmic artery Doppler velocimetry changes in patients with hypertensive disorders of pregnancy versus normotensive pregnant women in the third trimester of pregnancy	12
Pre-eclampsia: A great masquerader!	12

Regulation of NADH-Ubiquinone oxidoreductase 1alpha/beta subcomplex, 1 (NDUFAB1) expression in maternal endothelial cells by circulating factors in pathological pregnancies	12
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	12
Echocardiography abnormalities in severe preeclampsia	12
Long-term health after hypertensive pregnancy complications: Associations between adverse adiposity indices and dyslipidemia 1–3 years postpartum	12
Letter to the editor: Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	11
Cardiovascular risk management after hypertensive disorders and diabetes during pregnancy, in a multi-ethnic population: A qualitative study among women and healthcare providers	11
Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications	11
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	11
Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers	11
Cerebral hemodynamics and vasoconstriction in preeclampsia: From diagnosis to resolution	10
The protective effect of magnesium sulfate on placental inflammation via suppressing the NF-κB pathway in a preeclampsia-like rat model	10
Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy	10
Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction	9
Front Matter 1 - Full Title Page (regular issues)/Special Issue Title page (special issues)	9
The association of out-of-hospital postpartum NSAID use and post-discharge hypertension control for people with hypertensive disorders of pregnancy	9
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	9
Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio	9
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study	9
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	8
Withstanding the test of time: Morning versus afternoon/evening urine protein-to-creatinine ratios in preeclampsia	8
Editorial Board	8
RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy	8
Expediting labor induction in severe pre-eclampsia by earlier initiation of oxytocin after cervical ripening: A randomized study from India	8
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	8
Letter to editor – Placental basal plate myofibers and risk of hypertensive disorders of pregnancy	8
OP03_5. The association between preeclampsia in mothers and risk of kidney disease in offspring: a nationwide register-based cohort study	7
Eclampsia reduction with maternal early warning trigger tool	7
PO9_08. Hypertensive disorders of pregnancy - one year study (2021)	7
OP02_4. Distance of the home from hazardous waste sites, chronic hypertension and preeclampsia	7
SC3_3. FKBPL signalling in placental development and preeclampsia	7
OP15_6. Effect of pentaerythrityltetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at mid gestation – a double blinded randomised	7
PO8_5 Preeclampsia among women with covid-19 during pregnancy and its impact on maternal and perinatal outcomes: a multicenter study on covid in Brazil	7
PO9_10. Impact of antenatal glucocorticoids on neurotrophins levels in premature infants	7
PO9_03. Maternal ocular sonography: A window into the cerebral effects of antihypertensive therapy in preeclampsia	7
SC3_2. Endogenous retrovirus-encoded SYNCYTIN-2 contributes to exosome-mediated immunosuppression of T cells and is an early predictive biomarker for preeclampsia	7
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	7
OP01_5. Hypertensive pregnancy disease and SARS-COV-2/COVID-19: Results retrieved from the German national registry Cronos	7
Editorial Board	7
PO9_14. Preeclampsia education of the nation (India), empowering through education	7
OP09_6. Increased serum amyloid A1 in preeclampsia correlates with biomarker evidence of placental dysfunction: providing a link to future maternal cardiovascular disease?	7
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	7
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	6
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	6
PO3_14. Time to prioritise steroids in preterm pre-eclampsia	6
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	6
OP17_9. Evaluation of placental oxygenation and perfusion in a rat model of placental dysfunction using quantitative T2* mapping and 3D-DCE MRI	6
PO1_06. Hypertensive disorders in pregnancy as a major cause of preterm birth and adverse perinatal outcomes: findings from a Brazilian national survey	6
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	6
PO6_02. Association of maternal asthma and other allergic diseases with placental dysfunction and adverse obstetric outcome	6
PO2_04. Retinal microvascular vessel density in women 3 years after hypertensive disorder of pregnancy	6

CANCELLED : Maternal hemodynamic function in hypertensive disorders of pregnancy under antihypertensive therapy (HYPERDIP study)	6
PO1_14. CANCELLED: Women’s knowledge of the long-term cardiovascular risks associated with preeclampsia and gestational hypertension: a tertiary patient population survey	6
PO3_06. Oral antihypertensive agents in hypertensive pregnancies; results of a network meta-analysis	6
PO6_08. Adverse pregnancy outcomes and placental dysfunction assessed by maternal midpregnancy angiogenic factors	6
P-038. A survey for the need and potential acceptance for AI-based decision support tools in Obstetric Medicine	5
P-002. Evidence of neuroinflammation and injured blood–brain-barrier in eclampsia	5
First-trimester prediction model for placental vascular disorders: An observational prospective study	5
PO6_23. Título evaluation of endothelial quality of blood vessels and arterial tone in pregnant women with hypertensive disorders	5
Y-017. SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study	5
O-001. Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs	5
P-005. Involvement of RAGE pathway in visceral adipose tissue in preeclampsia	5
P-037. Revisiting ‘3 delays model[StQuote] for critical analysis of hypertensive maternal mortality in a developing nation	5
PO6_07. Ultra-high sensitive c-reactive protein (UHSCRP) in the first trimester of pregnancy in normal and adverse outcome	5
Y-003. Longitudinal serum cytokine profiles in gestational hypertension and preeclampsia	5
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	5
P-025. Comparison of methods for determining PlGF and sFlt-1 levels in maternal circulation in pregnancies complicated by placental dysfunction	5
Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia	5
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	5
Y-016. Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy	5
P-008. Predictive efficacy of sFlt-1/PlGF ratio in risk stratification on Indian hypertensive pregnant population	5
Childhood school outcomes for infants born to women with hypertensive disorders during pregnancy	4
GS-1. First 1000 days of life and non communicable diseases nexus	4
SY4-5. Temporary hypertension as well as white coat hypertension in the first trimester as risk factors for preeclampsia	4
Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia	4
The role of serum uric acid levels in the evaluation and prediction of adverse outcomes in hypertensive disorders of pregnancy	4
How digital health affects the patient-physician relationship: An empirical-ethics study into the perspectives and experiences in obstetric care	4
P-068. Fetal growth restriction in diagnosing preeclampsia is an important diagnostic criterion comparable to organ dysfunction	4
SY7-2. Management of hypertensive disorders of pregnancy based on home blood pressure	4
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to lett	4
P-102. Fetal growth restriction as the initial findings of preeclampsia is a clinical predictor of perinatal prognosis: A single-center retrospective study	4
SY5-4. An update on current and emerging therapies to treat or prevent preeclampsia	4
Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management	4
Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation	4
GS-5. Gestosis score a practical tool to predict and risk stratify preeclampsia-gestosis	4
SY9-2. Hypertensive disorders of pregnancy and future maternal cardiovascular health	4
SY10-2. Management of severe postpartum TMA	4
P-079. Significance of hemodynamic indices in prediction of blood pressure elevation in pregnant women with chronic hypertension	4
Inappropriate left ventricular mass after HELLP syndrome inappropriate LVM after HELLP syndrome	4
PS-1. Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP	4
SY2-1. Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia	4
Glycosylated fibronectin point-of-care test- role in prediction of pregnancy complications	4
Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia	4
Prediction of adverse neonatal outcome at admission for early-onset preeclampsia with severe features	4
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	4
SY9-5. The approaches and problems in the care of the postpartum women who suffered from hypertensive disorders of pregnancy	4
Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: Bridging epidemiological knowledge into personalized postpartum care and follow-up	3
Patient and provider perception of home blood pressure monitoring kits	3
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	3
Identification of potential crucial genes associated with early-onset preeclampsia via bioinformatic analysis	3
Interleukin-17 induces hypertension but does not impair cerebrovascular function in pregnant rats	3
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	3
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	3
Corrigendum to “Cardiovascular effects of severe late-onset preeclampsia are reversed within six months postpartum” [Preg. Hypertens. 19 (2020) 18–24]	3
Stage 1 hypertension defined by the 2017 ACC/AHA guidelines and neonatal outcomes: Systematic review and meta-analysis	3
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	3
Dietary protein source contributes to the risk of developing maternal syndrome in the Dahl salt-sensitive rat	3
Preeclampsia and high blood pressure in early pregnancy as risk factors of severe maternal cardiovascular disease during 50-years of follow-up	3
Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: A meta-analysis of cohort studies	3
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	3
Preconception ovarian reserve and placenta-mediated pregnancy complications among infertile women	3
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia – A qualitative study	3
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women	3
Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis	3
Machine learning, advanced data analysis, and a role in pregnancy care? How can we help improve preeclampsia outcomes?	3
Association of activin A and postpartum blood pressure in peripartum cardiomyopathy	3
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	3
The plasma antioxidant vitamin status of the INTAPP cohort examined: The unsuspected importance of β-carotene and γ-tocopherol in preeclampsia	3
Association of NLRP3 and IL-4 VNTR polymorphisms and genetic susceptibility to preeclampsia: A case-control study	3
Decreased expression of caveolin-1 have relevance to promoted senescence in preeclamptic placenta	3
Histopathological features of kidney and renal prognosis in patients with preeclampsia	3
Evaluation of Klotho gene expression and NGAL levels following acute kidney injury during pregnancy hypertensive disorders	3
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	3
Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: Results from a national multicenter study on COVID in Brazil, the REBRACO initiative	3
Patients and health care workers perceived challenges in managing preeclampsia, in Malawi	3
Association between aspirin use during pregnancy and cardiovascular risk factors 2–7 years after delivery: The nuMoM2b Heart Health Study	3
Inpatient versus outpatient management of gestational hypertension or preeclampsia without severe features	2
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	2
P085. Should we consider Hypertensive Disorders of Pregnancy a risk factor for postpartum haemorrhage?	2
P-016. Sub-analysis of the Japanese population from PROGNOSIS Asia study assessing the sFlt-1/PlGF ratio for short-term prediction of preeclampsia	2
P-097. Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy – A qualitative rerspective	2

Response to Letter to the Editor: Comment on Article: Aspirin resistance in pregnancy is associated with reduced interleukin-2 concentration in maternal serum	2
SY9-4. The role of exercise in the prevention of preeclampsia and gestational hypertension	2
LEANBH study: Device satisfaction study for the use of a novel connected home blood pressure system in pregnancy; a prospective cohort study	2
SY4-2. Non-coding RNAs in extravillous trophoblast cells	2
miR-204-5p promotes preeclampsia serum-induced injury in human umbilical vein endothelial cells through regulation of the PTPRJ/Notch axis	2
P-072. Severe anemia and preeclampsia – Case report and literature review	2
P-073. A case of preeclampsia complicated with posterior reversible encephalopathy syndrome and central serous chorioretinopathy	2
High prevalence of neuroimaging abnormalities in eclampsia: Justifying the routine use of non-contrast CT in resource-limited settings	2
P-055. Erythropoietin expression on fetal red blood cells in preeclampsia	2
P-048. Stringent laboratory monitoring of pre-eclampsia and gestational hypertension: Improving care in low-resource settings	2
O-010. Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy	2
O-004. Circulating SIGLEC6 is deranged in preeclampsia and may be a biomarker of disease severity	2
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	2
Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes	2
SY8-1. Maternal diet and gut microbiota: effects on gut blood pressure and metabolism	2
Ethnocultural status and risk of preeclampsia in a Canadian setting	2
ES-2. Integrity and usefulness of research in pre-eclampsia	2
P-093. Elimination of sFLT1 by therapeutic plasma exchange in early-onset preeclampsia/HELLP may improve placental dysfunction and pregnancy duration	2
P-081. Hyperaldosteronism in pregnancy: a case control study	2
P-059. Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy	2
Management of hypertension in the early postpartum: A randomized controlled trial	2
Retrospective study for classifying hypertensive disorders of pregnancy by time of onset	2
Systematic treatment and management of postpartum hypertension using remote patient monitoring	2
P-043. Simvastatin attenuates the symptoms of preeclampsia murine model	2
SY2-2. The development of preeclampsia hypotheses in the last two decades: what has been disproved and what is still valid?	2
Maternal characteristics impact the relationship between fetal sex and superimposed preeclampsia	2
Appraisal of hepatocyte growth factor signal transduction in the duality of HIV associated pre-eclampsia	2
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	2
SY3-3. Possible role of the NLRP3 inflammasome in preeclampsia	2
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	2
SA. RNA interference therapy for preeclampsia	2
P-092. Implementation of angiogenic biomarkers for the diagnosis of pre-eclampsia in Greater Manchester	2
SY6-1. Statins for preeclampsia	2
P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy	2
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	1
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	1
Pregnancy outcomes of women presenting with stage 1 hypertension during the first prenatal clinic visit before 20 gestational weeks	1
PO2_12. A systematic review about the association among severe maternal morbidity and hypertension disorders	1
Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio	1
PO7_7. Ability and accuracy of patient-performed blood pressure monitoring among pregnant women in Ghana	1
Policy Lab as an engagement tool for improving pre-eclampsia management in a high-burden setting	1
PO1_09. Evaluation of biophysical markers associated with arterial hypertension in women belonging to the 1978/79 cohort in the city of Ribeirão Preto/SP	1
Preconception dietary inflammatory index and hypertension disorders of pregnancy: The Japan environment and children's study	1
Analysis of complications of pre-eclampsia in a tertiary care hospital	1
OP03_4. Association between preeclampsia in daughters and risk of ischemic events in parents	1
Factors associated with successful trial of labor after caesarean section in women complicated with eclampsia	1
Mental health in the two years following hypertensive and normotensive pregnancy: The Postpartum, Physiology, Psychology and Paediatric follow-up (P4) cohort study	1
The blood pressure postpartum (BP2) RCT: Testing utility of structured follow-up and lifestyle behaviour change interventions in the first 12 months following hypertensive pregnancy	1
The diagnostic Accuracy of Visual versus automated dipstick proteinuria testing in Pregnancy: A systematic review and Meta-Analysis	1
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	1
P107. Characteristics of pre-hospital care of pregnant women with hypertensive syndrome	1
P-028. Study of mean platelet volume in first trimester of pregnancy and its association with development of preeclampsia	1
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	1
Y-015. Hypertensive disorders of pregnancy and alterations in brain metabolites in preterm infants: a multi-voxel proton MR spectroscopy study	1
Ophthalmic ultrasound in the prediction of preeclampsia	1
Current state of affairs: A study regarding diagnosis, treatment and use of home blood pressure monitoring for hypertension in pregnancy	1
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	1
SC4_4. Pathways to pre-eclampsia: learning from lived experience about the risk factors for pre-eclampsia	1
PO6_03. Do lower blood pressure cut-offs in obese pregnant women identify women at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of upbeat data	1
Blood pressure lability within individual office visits: A secondary analysis of the Control of Hypertension In Pregnancy Study (CHIPS) trial	1
PO8_2. B cells contribute to hypertension and at1-AA production in preeclampsia or covid-19 infection during pregnancy	1
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	1
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	1
Reduced urinary angiotensinogen excretion in preeclampsia	1
Clinical profile and outcomes of patients with hypertensive disorders in pregnancy on multiple anti-hypertensive drugs	1
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	1
Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia	1
Response to letter to the editor	1
SC4_5. Understanding the experience of partners to women whose pregnancy is complicated by preeclampsia	1
Increased oxidative stress and endothelial activation in umbilical veins from pregnancies diagnosed with preeclampsia	1
Comparative study of Morphometric and histological changes of the human placenta in IVF conception and spontaneous conception	1
Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study	1
P-019. Pre-pregnancy maternal stress leads to impaired vascular function during pregnancy	1
COVID-19 and hypertension in pregnancy: An analysis of clinical outcomes and sFlt-1 / PlGF biomarkers in vaccinated pregnant women	1
Validation of the French translation of a self-administered questionnaire looking for a history of pre-eclampsia	1
A Policy Lab to accelerate translation of novel research into policy to improve timely detection and appropriate action in care of women with Pre-eclampsia in Sierra Leone	1
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	1
PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	1
SC3_4. Fluid shear stress affects metabolism in human villous trophoblasts	1
PO7_3. Patient perception of home blood pressure monitoring kits	1
Screening of uterine artery Doppler in predicting preeclampsia and fetal growth restriction	1
The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin	1
Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue	1
Prevalence of long term metabolic, cardiovascular, cerebrovascular and renal disease in patients with hypertensive disorders in pregnancy remote from pregnancy (POMCH)	1
PO9_04. CANCELLED : Test of scale of cradle vital signs alert device and training to improve maternity care in Sierra Leone: evaluation of adoption and effect on maternity referrals	1
Functionality, anxiety, and depression: Use of the WOICE tool in hypertensive pregnant and postpartum women	1
PO7_5. ‘I don’t really understand this BP’: women’s knowledge, attitudes, and experiences with preeclampsia in Ghana	1
Applied numeracy among pregnant women engaged in home BP monitoring in Ghana	1
Trends and predictors of eclampsia among singleton and multiple gestations in the United States, 1989–2018	1
Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010–2019	1
Letter to the Editor RE: Healthy and preeclamptic pregnancies show differences in Guanylate-Binding Protein-1 plasma levels	1
Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	1
P-032. Silibinin downregulates the expression of the Th1 and Th17 profiles by the modulation of STATs and transcription factors in pregnant women with preeclampsia	1
O-011. Pre-pregnancy stress leads to impaired placental development, post-partum high blood pressure and vascular dysfunction	1
Immature Platelet fraction (IPF) in preeclampsia: A prospective comparative study	1